Showing results (61-70 of 230) with videos related to
Sort By:
Pageof 23
Cancer Chemotherapy and Pharmacology|April 21, 2017
Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I studyHang Quach, Darrell White, Andrew Spencer, et al.Journal of Translational Medicine|September 8, 2016
Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myelomaRachel E Cooke, Nicholas A Gherardin, Simon J Harrison, et al.Development and Psychopathology|February 17, 2021
Lower implicit self-esteem as a pathway linking childhood abuse to depression and suicidal ideationAzure Reid-Russell, Adam Bryant Miller, Dario Cvencek, et al.Journal of Cognitive Neuroscience|October 16, 2018
Emotion Reactivity and Regulation in Adolescent Girls Following an Interpersonal RejectionAdam Bryant Miller, Mitchell J Prinstein, Emily Munier, et al.The American Journal of Sports Medicine|February 22, 2011
Performance on the single-leg squat task indicates hip abductor muscle functionKay M Crossley, Wan-Jing Zhang, Anthony G Schache, et al.Sensors (Basel, Switzerland)|September 9, 2022
Machine Learning Derived Lifting Techniques and Pain Self-Efficacy in People with Chronic Low Back PainTrung C Phan, Adrian Pranata, Joshua Farragher, et al.The Plant Cell|May 10, 2011
Microtubule-associated proteins MAP65-1 and MAP65-2 positively regulate axial cell growth in etiolated Arabidopsis hypocotylsJessica R Lucas, Stephanie Courtney, Mathew Hassfurder, et al.Sensors (Basel, Switzerland)|February 24, 2024
Regression-Based Machine Learning for Predicting Lifting Movement Pattern Change in People with Low Back PainTrung C Phan, Adrian Pranata, Joshua Farragher, et al.Clinical Lymphoma, Myeloma & Leukemia|March 14, 2025
Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple Myeloma Treated With Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone: An Analysis of Patient-Reported Outcomes From the Phase 3 CANDOR TrialKatja Weisel, Maria-Victoria Mateos, Ola Landgren, et al.British Journal of Haematology|June 26, 2023
A sequential cohort study evaluating single-agent KappaMab and KappaMab combined with lenalidomide and low-dose dexamethasone in relapsed and/or refractory kappa light chain-restricted multiple myeloma (AMaRC 01-16)Andrew Spencer, Anna Kalff, Jake Shortt, et al.Pageof 23